Clonidine Pill is one of 93 small molecule programs targeting Chronic pain. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
190 competitors in Obesity
Cagrilintide
Maridebart Cafraglutide
Retatrutide
Decadron
Revlimid
IBI362
Eloralintide
Clonidine Pill
Survodutide
Semaglutide or Tirzepatide
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details